1-3 of 3
Alan Shields
Close
Sort by
Journal Articles

Development and Content Validity of a Novel Myelodysplastic Syndromes Symptom Daily Diary

Susan Vallow, Patricia Brandt, Nina Galipeau, Roger Lamoureux, Sylvia Su, Annette Yim, Connor Volpi, Alan Shields
Journal: Blood
Blood (2021) 138 (Supplement 1): 4654.
https://doi.org/10.1182/blood-2021-151080
Published: 2021
Journal Articles

Qualitative Assessment Of Symptoms and Functional Impact In Relapsed/Refractory Multiple Myeloma Patients and Comparison To The EORTC QLQ-C30 and My-20, FACT-MM, and MDASI-MM

Peter C Trask, PhD, MPH, Fiona Taylor, MBiochem, Alan Shields, PhD, Meghan Gallagher, MSc, Jyotsna Mehta, MSc, Catherine Foley, MPH, Funke Olude, MPH, Roger Lamoureux, Ramon Iovin, PhD, Karl Hsu, MD
Journal: Blood
Blood (2013) 122 (21): 2989.
https://doi.org/10.1182/blood.V122.21.2989.2989
Published: 2013
Journal Articles

Associations Between Improvements in Myelofibrosis (MF) Symptoms and Quality of Life Measures with Splenomegaly Reduction in COMFORT-I: A Randomized, Double-Blind, Phase III Trial of the JAK1 and JAK2 Inhibitor Ruxolitinib Versus Placebo in Patients with MF,

Ruben A. Mesa, MD, Jason Gotlib, MD, MS, Vikas Gupta, MD, FRCP, FRCPath, John F. DiPersio, MD, PhD, John Catalano, MD, Michael W. Deininger, Alan Shields, PhD, Carole B. Miller, MD, Richard T. Silver, MD, Moshe Talpaz, MD, Elliott F. Winton, MD, Jimmie H. Harvey, Jr., MD, Thomas Hare, PhD, Sue Erickson-Viitanen, PhD, William Sun, PhD, Victor A. Sandor, MD, CM, Richard S. Levy, MD, Hagop M. Kantarjian, Srdan Verstovsek, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3842.
https://doi.org/10.1182/blood.V118.21.3842.3842
Published: 2011